Navigation Links
Genetic Mutations Linked to Deadly Brain Cancer
Date:2/18/2009

Tests could one day individualize treatment, researcher says

WEDNESDAY, Feb. 18 (HealthDay News) -- Researchers report that they've discovered two genetic mutations that play an important role in the development of some particularly dangerous types of brain tumors.

The findings "open a completely new avenue" to better treatments for one of the most deadly forms of cancer, said Dr. Hai Yan, lead author of a study published in the Feb. 19 issue of the New England Journal of Medicine.

For the moment, the research doesn't appear likely to result in immediate benefits for patients. But ultimately, it may allow physicians to "understand what kind of tumor patients have and give them the right treatment," said Yan, an assistant professor of pathology at Duke University, in Durham, N.C.

At issue are brain tumors known as gliomas. About 10,000 Americans are diagnosed with the tumors each year -- the most famous current patient is Senator Edward Kennedy -- and the prognosis is grim. While the cancer typically doesn't spread to other parts of the body, it can create havoc in the brain and cause death within months.

The tumors are hard to treat. Chemotherapy and radiation can damage healthy brain tissue and only allow patients to live a few months longer. The only effective drug appears to extend lifespan for just a couple of months, Yan said.

Surgery is an option, but "gliomas generally spread in the brain the way roots spread from a plant," Yan said. "It is very difficult to completely remove the tumors."

In the new study, Yan and colleagues found that two genetic mutations appear in more than 70 percent of certain kinds of these tumors.

"You could use these genes to distinguish a subtype of glioma," Yan said. "Two tumors may look like a duck and walk like a duck, but the two tumors may be quite different."

Once a test determines the type of a glioma in a patient, doctors could conceivably choose from an array of treatments. "You can give one kind of patients one kind of drug, and others another kind of drug," Yan said.

That kind of tailored treatment awaits on the horizon. But for the time being, a genetic test that costs less than $100 could provide information to patients about their prognosis by revealing the type of tumor they have, Yan said.

The results are promising because they reveal that there two distinct types of tumor, said Dr. Craig Thompson, chairman of the University of Pennsylvania's Department of Cancer Biology and Medicine.

"They are caused by different mutations and therefore are likely to respond to different therapies," said Thompson, who wrote a commentary accompanying the study. "Before this, we did not know what caused these tumors."

More information

Learn more about brain cancer from the National Institutes of Health.



SOURCES: Hai Yan, M.D., Ph.D., assistant professor, Department of Pathology, Duke University, Durham, N.C.; Craig Thompson, M.D., chairman, Department of Cancer Biology and Medicine, University of Pennsylvania, Philadelphia; Feb. 19, 2009, New England Journal of Medicine


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Genetics May Help Fine-Tune Warfarin Dosage
2. Exploring Genetic Link Between Migraines, Cardiovascular Trouble
3. Researchers identify novel genetic markers linked to increased risk of heart attack
4. Genetic Code of Common Cold Cracked
5. Study: Genetic Risk for Substance Use Can be Neutralized by Good Parenting
6. Study: Genetic risk for substance use can be neutralized by good parenting
7. BioInformatics, LLC, A Recognized Sponsor of First Annual Consumer Genetics Show in Boston, June 9-11, 2009
8. Genetic Test for Heart Disease Risk in the Works
9. ANA and ISONG Co-Publish Genetics and Ethics in Health Care: New Questions in the Age of Genomic Health
10. American College of Medical Genetics Foundation Unveils New Website: ACMG Foundation Supports Medical Genetics Research, Education and Practice
11. Interleukin Genetics to Present at G-2 Reports Molecular Diagnostic Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genetic Mutations Linked to Deadly Brain Cancer
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... ... expansion of its services to provide one resource, from start to finish, for ... preparation, Life Safety Statement of Condition surveys requested by the Joint Commission, and ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... services today announced a strategic partnership with Five9 (Nasdaq: FIVN), a leading ... one of Avaya’s largest Platinum Business Partners, is a leading provider of ...
(Date:5/24/2016)... ... May 24, 2016 , ... Mental health watchdog ... Church of Scientology and renowned professor of psychiatry Thomas Szasz, is continuing its protest ... An Industry of Death” exhibit in Atlanta, Georgia. The opening of the exhibit follows ...
(Date:5/24/2016)... ... ... Boyd Industries, a leading supplier of dental chairs and cabinetry , will ... dentistry , at AAPD 2016, the annual conference and trade show of the American ... keeps dental hand pieces and other anxiety-provoking pieces of the dental delivery system out ...
(Date:5/24/2016)... ... May 24, 2016 , ... The Radiosurgery ... practice of radiosurgery, is recognizing five medical residents and students for their outstanding ... radiotherapy (SBRT). The awards will be presented at the 2016 SRS/SBRT Scientific Meeting ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... 2016 Les ... la première endoprothèse à double thérapie au ... portant sur les membres inférieurs et la ... entreprise mondiale spécialisée dans la fourniture de ... a élargi son portefeuille pour inclure des ...
(Date:5/23/2016)... PUNE, India , May 23, 2016 ... is spread across 163 pages, profiles 12 companies and ... 280 tables and figures on the industry and its ... study that is comprehensive in nature, details the current ... of the industry including definitions, classifications, applications and industry ...
(Date:5/23/2016)... , May 23, 2016 The World Health ... PrePex device to include adolescents aged 13 years, and ... can be offered for adult and adolescent males in the ... . PrePex was the first male circumcision device to ... MedTech,s CEO, Eddy Horowitz said: " The ...
Breaking Medicine Technology: